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STUDY OF SERUM LEVEL OF CHEMERIN- A NOVEL MARKER 
OF METABOLIC  SYNDROME 
BACKGROUND: 
                    Cardiovascular disease is one of the major alarming cause of morbidity and mortality. 
Obesity is a major risk factor for the CVD. Chemerin is  a novel adipokine secreted by adipocytes 
which  has  role in the metabolism of adipose tissue and in immune response regulation  which is 
important  in the pathogenesis of the metabolic syndrome. Estimation of this adipokine could benefit in 
the early detection  of metabolic syndrome . 
AIMS AND OBJECTIVES 
                    To estimate serum chemerin as a marker of metabolic syndrome. To study  the relation 
between the levels  of serum chemerin with individual components of metabolic syndrome and  to 
evaluate the association of Chemerin with CAD risk in individuals  with  metabolic syndrome. 
MATERIALS AND METHODS 
                        This cross-sectional study was  conducted at MGMGH,Trichy. Anthropometric 
measurements BMI, WC and  HC are taken. Serum analyses  done for chemerin, , triacylglycerides, 
total cholesterol, HDLcholesterol,   and  glucose in 45 healthy subjects and 45 subjects metabolic  
syndrome . LDL ,VLDL,CRI I,CRI II ,AC & AIP were calculated .Data  was expressed as Mean  ± 
Standard Deviation.  
RESULTS 
                            Student t-test and Pearson’s correlation were used to compare the variables. A   
p value of  ≤ 0.05 is considered statistically significant. Subjects with  Met S had significantly higher 
serum chemerin levels than controls (mean 260.40 vs.93.11 ng/ml  P < 0.01). There is positive 
correlation of chemerin levels with Met S parameters such as WC,BP,TAG,FBG  (P < 0.01).The 
atherogenic indices CRI I, CRI II ,AC and AIP increases linearly with increase in serum chemerin level 
(P < 0.01). 
 CONCLUSION: 
               The present study demonstrated  that serum chemerin levels are significantly increased 
in persons with Met S. The   chemerin levels increases   progressively as the number of components of 
Met S increases and there is a statistically significant positive linear correlation between Chemerin 
levels and newer atherogenic indices. Hence the estimation of chemerin  may be used as  marker for 
early prediction of atherosclerosis as well as Metabolic Syndrome.  
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